Human CXCR4 Recombinant
$160.00 – $1,950.00
| accession | P61073 |
| Source | Optimized DNA sequence encoding extracellular domain of Human CXCR4 MET1 -SER46) including a N-terminal IgG1 Fc tag was expressed in HEK293 cells. |
| Molecular weight | Recombinant human CXCR4 is a protein consisting of 390 amino acid residue subunits,due to glycosylation migrates as an approximately 45kDa protein on reduced SDS-PAGE. |
| Purity | >95%, as determined by SDS-PAGE and HPLC |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg). |
| Presentation | Recombinant Human CXCR4 is lyophilized from 0.2 μm filtered PBS solution, pH7.2 , 5% Trehalose. |
| Storage | Recombinant CXCR4 can be stored in working aliquots at 2° - 8° C for one month, or at -20°C to-70°Cfor twelve months. Avoid repeated freeze/thaw cycles. |
| Usage | This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Interactor | P51681 |
| Interactor | Q99523 |
| Biological Process | Host-virus-interaction |
| Molecular function | Transducer |
| Molecular function | Receptor |
Methods
MPLA-activated tDCs acquire secondary lymphoid homing capacity in response to CCR7 and CXCR4 ligands compared to non-activated tDCs.
|